Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MVIH
   Synonyms AK094613
   Region NA    Sequence
   Ensembl NA
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR, Western blot, etc.
   Sample Hepatoma cell line HepG2, liver tumor-derived cell lines SKHEP-1, Huh7
   Expression Pattern up-Regulated
   Function Description

Our data suggests that deficiency or loss of functional mutations of ARID1A in HCC cells might contribute to the increased activity ofcertain cancer-promoting lncRNAsã??AIRD1A fragments (A-1, aa 1e310; A-2, aa 311e600; A-3, aa 601e950; A-4, aa 951e1300; A-5, aa 1301e1600; A-6, aa 1601e1900; A-7, aa 1901e2285) were amplified by PCR and subcloned into pGEX-4T-1 vectors (GE Healthcare Life Sciences) to generate recombinant GST-ARID1A fusion proteins. As a subunit of SWI/SNF complex, ARID1A could contribute to its chromatin remodeling activity by recruiting and binding of specific transcription factor and transcriptional coactivator/corepressor complexes.ARID1A, encoding the BAF250a subunit of SWI/SNF complex, has a high mutation frequency in numerous types of cancer.

   Pubmed ID 28716731
   Year 2017
   Title ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH.
   External Links
   Links for  MVIH GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.